Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q2 2021 Results – Earnings Call Transcript
Adamas Pharmaceuticals, Inc. (ADMS) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET
Company Participants
Peter Vozzo – Investor Relations
Neil McFarlane – Chief Executive Officer
Vijay Shreedhar – Chief Commercial Officer
Chris Prentiss – Chief…
